Skip to main content
. 2013 May;46(5):252–257. doi: 10.5483/BMBRep.2013.46.5.172

Fig. 2. FAP-shRNA targets FAP-mediated inhibition of tumor growth. (A) Tumor sizes (mm3) (n = 7 per group) were recorded on days 8, 11, 14, 17, 19, 21, 23, and 25 after tumor inoculation. (B) Tumor weight on day 25. *P < 0.05 compared with controls.

Fig. 2.